Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.59 is 53% below its 5-year average of 7.61, near the low end of its 5-year range (0.43–28.78).
As of the fiscal period ended Tuesday, June 30, 2026. 88.34% above its 12-month average of 1.90.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.59.
CURRENT RATIO
3.59
CURRENT RATIO AVG TTM
1.90
CURRENT RATIO AVG 3Y
3.46
CURRENT RATIO AVG 5Y
7.61
CURRENT RATIO AVG 10Y
3.65
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+88.34%
CURRENT VS 3Y AVG
+3.72%
CURRENT VS 5Y AVG
-52.85%
CURRENT VS 10Y AVG
-1.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-4.62%
vs the sector median at left
XORTX Therapeutics Inc.
Market Cap
$481786.00
Current Ratio
3.59
TTM Avg
1.90
3Y Avg
3.46
5Y Avg
7.61
Market Cap
$403887.00
Current Ratio
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$378849.00
Current Ratio
9.97
TTM Avg
8.62
3Y Avg
13.45
5Y Avg
8.98
Market Cap
$667469.00
Current Ratio
7.93
TTM Avg
5.73
3Y Avg
3.60
5Y Avg
2.83
Market Cap
$824550.00
Current Ratio
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $481786.00 | 3.59 | 1.90 | 3.46 | 7.61 |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | 1.70 | 2.81 | 3.10 | 14.50 |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | 0.06 | 0.15 | 3.14 | 7.02 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 9.97 | 8.62 | 13.45 | 8.98 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | 7.93 | 5.73 | 3.60 | 2.83 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | 2.41 | 3.89 | 3.24 | 3.47 |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 2.14 | 1.09 | 1.79 | 1.48 |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | 2.31 | 2.02 | 1.49 | 1.35 |
Current Ratio
3.59
Quick Ratio
3.59
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.59 |
| 2026-03-31 | 0.43 |
| 2025-12-31 | 2.11 |
| 2025-09-30 | 1.62 |
| 2025-06-30 | 1.78 |
| 2025-03-31 | 2.78 |
| 2024-12-31 | 3.53 |
| 2024-09-30 | 1.40 |
| 2024-06-30 | 6.43 |
| 2024-03-31 | 13.68 |
| 2023-12-31 | 4.93 |
| 2023-09-30 | 9.44 |
| 2023-06-30 | 15.82 |
| 2023-03-31 | 13.69 |
| 2022-12-31 | 7.21 |
| 2022-09-30 | 6.66 |
| 2022-06-30 | 14.09 |
| 2022-03-31 | 19.37 |
| 2021-12-31 | 28.78 |
| 2021-09-30 | 0.63 |
| 2021-06-30 | 1.77 |
| 2021-03-31 | 1.68 |
| 2020-12-31 | 1.99 |
| 2020-09-30 | 2.41 |
| 2020-06-30 | 2.99 |
| 2020-03-31 | 2.64 |
| 2019-12-31 | 0.63 |
| 2019-09-30 | 0.71 |
| 2019-06-30 | 0.79 |
| 2019-03-31 | 0.92 |
| 2018-12-31 | 1.09 |
| 2018-09-30 | 1.19 |
| 2018-06-30 | 1.56 |
| 2018-03-31 | 1.86 |
| 2017-12-31 | 0.06 |
| 2017-09-30 | 0.12 |
| 2017-05-31 | 1.42 |
| 2017-02-28 | 13.72 |
| 2016-11-30 | 18.28 |
| 2016-08-31 | 0.02 |
| 2016-05-31 | 0.34 |
| 2016-02-29 | 3.40 |
| 2015-11-30 | 9.43 |
| 2015-08-31 | 0.12 |
| 2015-05-31 | 0.25 |
| 2015-02-28 | 0.18 |
| 2014-11-30 | 0.00 |
| 2014-08-31 | 0.00 |
| 2014-05-31 | 0.00 |
